Gene Symbol | MAPK7 |
Entrez ID | 5598 |
Uniprot ID | Q13164 |
Description | mitogen-activated protein kinase 7 |
Chromosomal Location | chr17: 19,377,721-19,383,544 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000165 |
MAPK cascade |
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
IEA |
BP |
GO:0007049 |
cell cycle |
The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0018105 |
peptidyl-serine phosphorylation |
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. |
IEA |
BP |
GO:0019933 |
cAMP-mediated signaling |
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell. |
NAS |
BP |
GO:0030154 |
cell differentiation |
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
IEA |
BP |
GO:0030821 |
negative regulation of cAMP catabolic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate). |
NAS |
BP |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion |
Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion. |
IGI |
BP |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress |
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation). |
IMP |
BP |
GO:0043407 |
negative regulation of MAP kinase activity |
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. |
IEA |
BP |
GO:0045765 |
regulation of angiogenesis |
Any process that modulates the frequency, rate or extent of angiogenesis. |
IEA |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IGI |
BP |
GO:0050728 |
negative regulation of inflammatory response |
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
TAS |
BP |
GO:0051247 |
positive regulation of protein metabolic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein. |
IGI |
BP |
GO:0051344 |
negative regulation of cyclic-nucleotide phosphodiesterase activity |
Any process that stops or reduces the rate of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate. |
NAS |
BP |
GO:0051534 |
negative regulation of NFAT protein import into nucleus |
Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of an NFAT protein from the cytoplasm to the nucleus. |
IEA |
BP |
GO:0060761 |
negative regulation of response to cytokine stimulus |
Any process that decreases the rate, frequency, or extent of a response to cytokine stimulus. |
IGI |
BP |
GO:0070301 |
cellular response to hydrogen peroxide |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
IMP |
BP |
GO:0070377 |
negative regulation of ERK5 cascade |
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK5 cascade. |
IEA |
BP |
GO:0071363 |
cellular response to growth factor stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. |
IGI |
BP |
GO:0071499 |
cellular response to laminar fluid shear stress |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. |
IMP|TAS |
BP |
GO:0071560 |
cellular response to transforming growth factor beta stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus. |
IDA |
BP |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
Any process that stops, prevents or reduces the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
IMP |
BP |
GO:2000352 |
negative regulation of endothelial cell apoptotic process |
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process. |
IMP |
BP |
GO:2001240 |
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
IGI |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IDA |
CC |
GO:0005654 |
nucleoplasm |
That part of the nuclear content other than the chromosomes or the nucleolus. |
IDA|TAS |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
IDA|TAS |
CC |
GO:0016605 |
PML body |
A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection. |
IDA |
MF |
GO:0004674 |
protein serine/threonine kinase activity |
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
TAS |
MF |
GO:0004707 |
MAP kinase activity |
Catalysis of the reaction: protein + ATP = protein phosphate + ADP. This reaction is the phosphorylation of proteins. Mitogen-activated protein kinase; a family of protein kinases that perform a crucial step in relaying signals from the plasma membrane to the nucleus. They are activated by a wide range of proliferation- or differentiation-inducing signals; activation is strong with agonists such as polypeptide growth factors and tumor-promoting phorbol esters, but weak (in most cell backgrounds) by stress stimuli. |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0005524 |
ATP binding |
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
IEA |
MF |
GO:0051019 |
mitogen-activated protein kinase binding |
Interacting selectively and non-covalently with a mitogen-activated protein kinase. |
IPI |
Domain ID | Description |
---|---|
IPR000719 |
Protein kinase domain |
IPR003527 |
Mitogen-activated protein (MAP) kinase, conserved site |
IPR008271 |
Serine/threonine-protein kinase, active site |
IPR011009 |
Protein kinase-like domain |
IPR011989 |
Armadillo-like helical |
IPR017441 |
Protein kinase, ATP binding site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04010 |
MAPK signaling pathway |
KEGG |
hsa04540 |
Gap junction |
KEGG |
hsa04657 |
IL-17 signaling pathway |
KEGG |
hsa04722 |
Neurotrophin signaling pathway |
KEGG |
hsa04912 |
GnRH signaling pathway |
KEGG |
hsa04921 |
Oxytocin signaling pathway |
KEGG |
hsa05206 |
MicroRNAs in cancer |
KEGG |
hsa05418 |
Fluid shear stress and atherosclerosis |
KEGG |
WP437 |
EGF/EGFR Signaling Pathway |
WikiPathways |
WP3915 |
Angiopoietin Like Protein 8 Regulatory Pathway |
WikiPathways |
WP26 |
Signal Transduction of S1P Receptor |
WikiPathways |
WP306 |
Focal Adhesion |
WikiPathways |
WP481 |
Insulin Signaling |
WikiPathways |
WP3931 |
ESC Pluripotency Pathways |
WikiPathways |
WP185 |
Integrin-mediated Cell Adhesion |
WikiPathways |
WP382 |
MAPK Signaling Pathway |
WikiPathways |
WP1544 |
MicroRNAs in cardiomyocyte hypertrophy |
WikiPathways |
WP2795 |
Cardiac Hypertrophic Response |
WikiPathways |
WP2380 |
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway |
WikiPathways |
h_hdacPathway |
Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK) |
BioCarta |
h_mapkPathway |
MAPKinase Signaling Pathway |
BioCarta |
h_erk5Pathway |
Role of Erk5 in Neuronal Survival |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0020429 |
Hyperalgesia |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
PRKCD |
5580 |
Q05655 |
0.00 |
RPS6KA1 |
6195 |
Q15418 |
0.00 |
RPS6KA3 |
6197 |
P51812 |
0.00 |
FOS |
2353 |
P01100 |
0.52 |
MYC |
4609 |
P01106 |
0.52 |
RXRA |
6256 |
P19793 |
0.55 |
ACTB |
60 |
P60709 |
0.63 |
ACTN4 |
81 |
O43707 |
0.63 |
ATP5A1 |
498 |
P25705 |
0.63 |
GOLGB1 |
2804 |
Q14789 |
0.63 |
HSPA4 |
3308 |
P34932 |
0.63 |
HSPA5 |
3309 |
P11021 |
0.63 |
LDHC |
3948 |
P07864 |
0.63 |
PKM |
5315 |
P14618 |
0.63 |
PPP3CA |
5530 |
Q08209 |
0.63 |
FSCN1 |
6624 |
Q16658 |
0.63 |
TP53 |
7157 |
P04637 |
0.63 |
HSP90B1 |
7184 |
P14625 |
0.63 |
YWHAG |
7532 |
P61981 |
0.63 |
YWHAH |
7533 |
Q04917 |
0.63 |
YWHAZ |
7534 |
P63104 |
0.63 |
NR1I2 |
8856 |
O75469 |
0.63 |
MAP3K2 |
10746 |
Q9Y2U5 |
0.63 |
UBE2C |
11065 |
O00762 |
0.63 |
GANAB |
23193 |
Q14697 |
0.63 |
FGF21 |
26291 |
Q9NSA1 |
0.63 |
GPSM3 |
63940 |
Q9Y4H4 |
0.63 |
MYLK2 |
85366 |
Q9H1R3 |
0.63 |
EGLN3 |
112399 |
Q9H6Z9 |
0.63 |
TUBB |
203068 |
P07437 |
0.63 |
APP |
351 |
P05067 |
0.66 |
NFE2L2 |
4780 |
Q16236 |
0.68 |
DSC1 |
1823 |
Q08554 |
0.72 |
DSG1 |
1828 |
Q02413 |
0.72 |
JUP |
3728 |
P14923 |
0.72 |
PFDN1 |
5201 |
O60925 |
0.72 |
PFDN2 |
5202 |
Q9UHV9 |
0.72 |
PFDN4 |
5203 |
Q9NQP4 |
0.72 |
PFDN5 |
5204 |
Q99471 |
0.72 |
VBP1 |
7411 |
P61758 |
0.72 |
PFDN6 |
10471 |
O15212 |
0.72 |
HSP90AB1 |
3326 |
P08238 |
0.73 |
PRKCZ |
5590 |
Q05513 |
0.73 |
CDC37 |
11140 |
Q16543 |
0.73 |
ETS1 |
2113 |
P14921 |
0.79 |
GAPDH |
2597 |
P04406 |
0.82 |
YWHAE |
7531 |
P62258 |
0.82 |
MAPK7 |
5598 |
Q13164 |
0.83 |
GJA1 |
2697 |
P17302 |
0.88 |
MEF2A |
4205 |
Q02078 |
0.88 |
PML |
5371 |
P29590 |
0.88 |
RAF1 |
5894 |
P04049 |
0.88 |
SGK1 |
6446 |
O00141 |
0.88 |
MEF2D |
4209 |
Q14814 |
0.89 |
MAP2K5 |
5607 |
Q13163 |
0.89 |
YWHAB |
7529 |
P31946 |
0.89 |
MEF2C |
4208 |
Q06413 |
0.90 |
DUSP1 |
1843 |
P28562 |
0.00 |
DUSP3 |
1845 |
P51452 |
0.00 |
DUSP4 |
1846 |
Q13115 |
0.00 |
DUSP7 |
1849 |
Q16829 |
0.00 |
EGF |
1950 |
P01133 |
0.00 |
MAPK3 |
5595 |
P27361 |
0.00 |
PRKCA |
5578 |
P17252 |
0.49 |
ELK4 |
2005 |
P28324 |
0.55 |
HSP90AA1 |
3320 |
P07900 |
0.63 |
NTRK1 |
4914 |
P04629 |
0.63 |
XPO1 |
7514 |
O14980 |
0.63 |
SH2D2A |
9047 |
Q9NP31 |
0.63 |
BAG3 |
9531 |
O95817 |
0.63 |
C5orf30 |
90355 |
Q96GV9 |
0.63 |
ZBED6CL |
113763 |
Q96FA7 |
0.63 |
DOT1L |
84444 |
Q8TEK3 |
0.72 |
PTPRR |
5801 |
Q15256 |
0.79 |